The Wnt5A/Protein Kinase C Pathway Mediates Motility in Melanoma Cells via the Inhibition of Metastasis Suppressors and Initiation of an Epithelial to Mesenchymal Transition

Abstract

We have shown that Wnt5A increases the motility of melanoma cells. To explore cellular pathways involving Wnt5A, we compared gain-of-function (WNT5A stable transfectants) versus loss-of-function (siRNA knockdown) of WNT5A by microarray analysis. Increasing WNT5A suppressed the expression of several genes, which were re-expressed after small interference RNA-mediated knockdown of WNT5A. Genes affected by WNT5A include KISS-1, a metastasis suppressor, and CD44, involved in tumor cell homing during metastasis. This could be validated at the protein level using both small interference RNA and recombinant Wnt5A (rWnt5A). Among the genes up-regulated by WNT5A was the gene vimentin, associated with an epithelial to mesenchymal transition (EMT), which involves decreases in E-cadherin, due to up-regulation of the transcriptional repressor, Snail. rWnt5A treatment increases Snail and vimentin expression, and decreases E-cadherin, even in the presence of dominant-negativeTCF4, suggesting that this activation is independent of Wnt/␤-catenin signaling. Because Wnt5A can signal via protein kinase C (PKC), the role of PKC in Wnt5A-mediated motility and EMT was also assessed using PKC inhibition and activation studies. Treating cells expressing low levels of Wnt5A with phorbol ester increased Snail expression inhibiting PKC in cells expressing high levels of Wnt5A decreased Snail. Furthermore, inhibition of PKC before Wnt5A treatment blocked Snail expression, implying that Wnt5A can potentiate melanoma metastasis via the induction of EMT in a PKC-dependent manner.The molecular mechanisms that govern the motility and metastasis of melanoma cells are not well understood. The prognosis for patients with recurrent melanoma has shown no improvement over the past 50 years. Many of these tumors are histopathologically quite similar but can be subclassified based upon their gene expression profiles (1, 2). In a study by Bittner et al. (1), the gene that best separated highly aggressive tumors from less aggressive tumors was WNT5A, which was consistently underexpressed in the less motile tumors. Wnt5A is a member of the Wnt family of proteins, which were first identified during studies of development in Drosophila (3) and in studies of the mouse mammary tumor virus (4). Unlike its family members Wnt1 and Wnt3A, which signal via the canonical Wnt pathway, resulting in the nuclear translocation of ␤-catenin, Wnt5A acts via G-protein-coupled receptors to activate protein kinase C (PKC) 6 and intracellular calcium (5, 6). The interplay between these two pathways is not well understood, but it does appear that the non-canonical Wnt pathway can inhibit ␤-catenin stabilization both in vitro in human HEK293 cells and in vivo in zebrafish (7,8).In melanoma cells with low motility and low expression of WNT5A, overexpressing WNT5A resulted in an increase in both the activation of PKC and an increase in motility (9). High expression of WNT5A in melanoma patients also correlated to poor outcome in this study. In addition, many studies have highligh...

Wnt-5a signaling restores tamoxifen sensitivity in estrogen receptor-negative breast cancer cells

“…Stimulation of cells was performed with rWnt-5a (0.6 g/ml) and recombinant Wnt-3a (0.1 g/ml and in a control experiment, 0.6 g/ml) (R&D Systems). The concentration of rWnt-5a used was based on numerous previous studies (40,41). The relevant concentration of rWnt-3a (0.1 g/ml) was chosen based on previous publications as well as information from the manufacturer, that rWnt-3a activity is approximately five times higher than that of rWnt-5a (41,42).…”

“…The concentration of rWnt-5a used was based on numerous previous studies (40,41). The relevant concentration of rWnt-3a (0.1 g/ml) was chosen based on previous publications as well as information from the manufacturer, that rWnt-3a activity is approximately five times higher than that of rWnt-5a (41,42). The Wnt-5a-derived formylated hexapeptide, Foxy-5 (formyl-MDGCEL), designed in our laboratory (10), and a formylated random hexapeptide (formyl-MSADVG) were synthesized by Inbiolabs (Tallinn, Estonia).…”

Take the Wnt out of the inflammatory sails: modulatory effects of Wnt in airway diseases

“…70,92 Interestingly, EMT is regulated by the Wnt/β-catenin and the noncanonical Wnt signaling pathway. [93][94][95] Also in the lung, Wnt signaling is involved in the regulation of EMT. Especially the cross-talk between Wnt/β-catenin signaling and TGFβ, which is a master regulator of EMT, seems to be pivotal in mediating EMT.…”

Noggin blocks invasive growth of murine B16‐F1 melanoma cells in the optic cup of the chick embryo

“…A complexity of factors is involved (e.g., E-Cadherin, 48 N-Cadherin, 49 Snail2, 50 Wnt-pathway). 51 The analysis of changes induced in the melanoma cell aggregates and the analysis of the transduction chains involved are under way.…”